Current Report Filing (8-k)
November 10 2021 - 6:00AM
Edgar (US Regulatory)
BRIGHTCOVE INC DE false 0001313275 0001313275 2021-11-09 2021-11-09
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): November 9, 2021
BRIGHTCOVE INC.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
DELAWARE
|
|
001-35429
|
|
20-1579162
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(I.R.S. Employer
Identification No.)
|
|
|
|
290 Congress Street, Boston, MA
|
|
02210
|
(Address of principal executive offices)
|
|
(Zip Code)
|
(888) 882-1880
Registrant’s telephone number, including area code
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered pursuant to Section 12(b) of the Act:
|
|
|
|
|
Title of each class
|
|
Trading
Symbol(s)
|
|
Name of each exchange
on which registered
|
Common Stock, par value $0.001 per share
|
|
BCOV
|
|
The NASDAQ Global Market
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
On November 1, 2021, Edenbrook Capital, LLC (“Edenbrook”) filed Amendment No. 6 to Schedule 13D/A, which included as Exhibit 1 a letter to the Board of Directors (the “Board”) of Brightcove Inc. (the “Company”).
On November 9, 2021, the Company’s Chairperson of the Board, Deborah Besemer, sent a letter responding to Edenbrook’s letter. The Chairperson’s response to the letter is attached to this current report as Exhibit 99.1 and is incorporated herein by reference.
Item 9.01.
|
Financial Statements and Exhibits.
|
(d) Exhibits
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
Date: November 9, 2021
|
|
|
|
Brightcove Inc.
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ Robert Noreck
|
|
|
|
|
|
|
Robert Noreck
|
|
|
|
|
|
|
Chief Financial Officer
|
Brightcove (NASDAQ:BCOV)
Historical Stock Chart
From Jun 2024 to Jul 2024
Brightcove (NASDAQ:BCOV)
Historical Stock Chart
From Jul 2023 to Jul 2024